Targeting IA-2 and GAD65 as a Cost-Saving Approach for Antibody Testing in Children With New-Onset Diabetes
Article Information
vol. 37 no. 1 90-92
Published By
Print ISSN
Online ISSN
History
- Published in print January 15, 2019.
- Published online ahead of print September 26, 2018.
Article Versions
- Previous version (September 26, 2018 - 07:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.
Author Information
Statistics from Altmetric.com
Article usage
In this Issue
January 2019, 37(1)
Targeting IA-2 and GAD65 as a Cost-Saving Approach for Antibody Testing in Children With New-Onset Diabetes
Jump to section
- Article
- Abstract
- Describe your practice setting and location.
- Describe the specific quality gap addressed through the initiative.
- How did you identify this quality gap? In other words, where did you get your baseline data?
- Summarize the initial data for your practice (before the improvement initiative).
- What was the timeframe from initiation of your quality improvement (QI) initiative to its completion?
- Describe your core QI team. Who served as project leader, and why was this person selected? Who else served on the team?
- Describe the structural changes you made to your practice through this initiative.
- Describe the most important changes you made to your process of care delivery.
- Optional: If you used the PDSA change model, provide details for one example in the following sections:
- Summarize your final outcome data (at the end of the improvement initiative) and how it compared to your baseline data.
- What are your next steps?
- What lessons did you learn through your QI process that you would like to share with others?
- Duality of Interest
- Footnotes
- Suppl Material
- Info & Metrics